(Q33465479)

27 July 2017

Does oral α-galactosidase relieve irritable bowel symptoms? (English)

1 reference

27 July 2017

Martti A Färkkilä

2

0 references

author name string

Markku Hillilä

1

1 reference

27 July 2017

Taina Sipponen

3

1 reference

27 July 2017

Janne Rajala

4

1 reference

27 July 2017

Jari Koskenpato

5

1 reference

27 July 2017

2 July 2015

1 reference

Scandinavian Journal of Gastroenterology

27 July 2017

1 reference

27 July 2017

51

1 reference

27 July 2017

1

1 reference

27 July 2017

16-21

1 reference

Functional bowel disorders

27 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Costs of irritable bowel syndrome in the UK and US.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Abdominal bloating: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Effects of beano on the tolerability and pharmacodynamics of acarbose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

Abdominothoracic mechanisms of functional abdominal distension and correction by biofeedback.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1063156

10.3109/00365521.2015.1063156

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference